Do GLP-1 Medications Affect PMS Cravings and Premenstrual Symptoms?

If you take a GLP-1 medication and also live with monthly premenstrual symptoms, you may wonder whether the two collide, especially around cravings. Here is a plain-language look at what is known and what is not.

The short answer

There is no strong, direct research showing that GLP-1 medications treat or worsen premenstrual syndrome (PMS). What we do know is that GLP-1 medications lower appetite and reduce cravings, while the luteal phase (the roughly two weeks before your period) is when many women report the strongest food cravings and appetite changes. So it is plausible that the two effects overlap in how you feel, but that is different from saying one fixes or fixes the other. Any change you notice is best treated as your own pattern to observe, not a proven effect.

Why cravings and symptoms ramp up before your period

PMS covers a wide range of physical and emotional symptoms that show up in the days before menstruation and usually ease once bleeding starts. According to the Office on Women's Health, these can include bloating, fatigue, mood swings, breast tenderness, and food cravings, and they are tied to the natural rise and fall of hormones across the cycle. ACOG notes that PMS is very common and that symptoms and their severity differ widely from woman to woman. Cravings, particularly for sweet or high-carbohydrate foods, are one of the classic premenstrual complaints, which is part of why the interaction with an appetite-lowering medication is a reasonable question to ask.

How GLP-1 medications act on appetite and cravings

GLP-1 medications work in part by slowing how quickly the stomach empties and by acting on appetite signaling, which tends to leave you feeling full sooner and for longer. Cleveland Clinic describes these drugs as increasing feelings of fullness and reducing appetite, which is a large part of why they affect eating and weight. Many people on these medications also report that food "noise" and cravings quiet down. Because premenstrual cravings and GLP-1 driven appetite changes are pulling in opposite directions, some women feel that the medication takes the edge off the luteal-phase urge to snack, while others still notice cravings creep back in that week.

What the overlap can feel like across your cycle

Both PMS and GLP-1 medications can involve the gut, so symptoms can be easy to confuse. Bloating, changes in digestion, and shifts in appetite show up on both lists, which means it is not always obvious whether a given week is "PMS," "the medication," or both at once. This is where paying attention to timing helps. Logging cravings, nausea, bloating, and hunger alongside where you are in your cycle can turn a vague sense of "something feels off" into a clear pattern you can actually see. If you track your doses and symptoms in rhythm with your cycle, it becomes easier to tell whether the luteal week reliably changes how a GLP-1 feels for you. A cycle-aware tool like PepFem is built around exactly this kind of side-by-side logging.

It is also worth remembering that GLP-1 medications can shift the cycle itself for some women, which can make premenstrual timing feel less predictable than it used to be. If your period has changed since starting treatment, that is a separate thread worth understanding on its own, and we cover it in why your period may change after starting a GLP-1.

What we still do not know

The honest picture is that research has not directly tested whether GLP-1 medications improve or worsen PMS or premenstrual cravings, and individual responses vary widely. PMS itself is highly individual, so two women on the same medication may describe completely different premenstrual experiences. If premenstrual symptoms are severe, disruptive, or newly different since starting a GLP-1, that is a conversation for your own clinician, who can look at your full history rather than a general pattern.